glp 1 drugs adverse effects GLP-1 Receptor Agonists Ozempic and other GLP-1 drugs
Description
American College of Cardiology
( Erratum in: Int J Clin Pract
Diabetologia 65 , 15411554 (2022)
Couzin-Frankel 22 Sept 2023 Barany, Barany)
Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I736 amide in type I diabetic patients
It should be pinpointed that while GIP acts almost exclusively at the pancreatic level, there are widely distributed receptors for GLP-1 (R-GLP1) in the endocrine pancreas ( and ), in heart, stomach, adipose tissue, vagus nerve and in various regions of the central nervous system
